Related Experiment Video
Updated: Aug 5, 2026

In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
Increased Adrenergic Receptor Expression in Meniere Disease
Adam Y Xiao1, Achilles Kanaris1, Masanori Ishii2,3
1Department of Head and Neck Surgery, University of California, Los Angeles, CA.
This study found increased alpha-1a adrenergic receptors (α1a-AR) in the inner ear of Meniere disease patients. This discovery may explain sympathetic hyperactivity and guide new treatments for this condition.
Area of Science:
- Otolaryngology
- Neuroscience
- Molecular Biology
Background:
- Meniere disease (MD) involves vertigo, hearing loss, and tinnitus, likely due to inner ear fluid imbalance.
- The exact molecular mechanisms of MD remain unclear, despite theories of autonomic dysfunction.
- Previous research suggests sympathetic hyperactivity, but molecular pathways are understudied.
Purpose of the Study:
- To investigate the expression of adrenergic receptors (AR) in the vestibular end organs of Meniere disease patients.
- To explore the molecular basis of potential sympathetic hyperactivity in MD pathogenesis.
- To identify specific AR subtypes involved in MD using human surgical tissue.
Main Methods:
- Collected vestibular end organs from MD patients (n=6) and controls (n=3).
- Utilized RNA in situ hybridization (RNAscope) for β1-, β2-, and α1a-AR transcripts.
- Employed immunofluorescence to confirm α1a-AR protein expression and identify vestibular hair cells (VHCs).
Main Results:
- Significantly increased α1a-AR transcripts were observed in MD utricles compared to controls.
- α1a-AR expression was concentrated in VHCs within the sensory epithelium of MD patients.
- Increased α1a-AR protein levels were confirmed via immunofluorescence in MD specimens.
Conclusions:
- This is the first study demonstrating elevated α1a-AR at both transcriptional and protein levels in Meniere disease.
- The findings provide a molecular link between MD and sympathetic hyperactivity.
- Increased α1a-AR expression may serve as a therapeutic target for Meniere disease management.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
